Pyroptosis‐Amplified Decoy Nanovesicles Orchestrate Pyroptotic Antigen Explosion and Endogenous Immune Revitalization for Potentiating Tumour Immunotherapy
Journal of Extracellular Vesicles · 2026
DOI: 10.1002/jev2.70356 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, 2026. Verfasst von Geng Dou und 21 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Key Labora…. Hauptthemen laut MEDLINE: Pyroptosis, Immunotherapy, Antigens, Neoplasm, Neoplasms. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Postdoctoral Program for Innovative Talents of China, National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Current advances in tumour immunotherapy remain constrained by inadequate cytotoxic T lymphocyte activation and the immunosuppressive tumour microenvironment. Innovative strategies are urgently required to enhance anti‐tumour immune potency for clinical improvements in immunotherapy‐resistant malignancies. Herein, we developed pyroptosis‐amplified decoy nanovesicles (PADVs) to synergistically dismantle tumour resistance mechanisms and rejuvenate endogenous anti‐tumour immunity. PADVs integrate checkpoint‐neutralizing capability with precise regulation of the pyroptosis molecular switch in tumour cells, thereby initiating a sequential activation cascade that enables efficient presentation of tumour‐specific antigens to the reshaped immune system. Systemically infused PADVs demonstrated dual‐targeting priority towards lymph node and deep tumour tissues, reversing immunosuppression through competitive blockade of PD‐1/PD‐L1 and SIRPα/CD47 axes while providing co‐stimulatory signals for immune reactivation. Furthermore, PADVs alleviate the epigenetic suppression of pyroptosis in tumours via cytosolic delivery of decitabine and LPS, enabling gasdermin D (GSDMD) upregulation and cleavage. This coordinated strategy reverses T cell exhaustion and triggers explosive antigen release via GSDMD‐mediated membrane perforation, initiating a self‐amplifying immune cascade involving dendritic cell activation, effector and memory T cell formation. Consequently, PADVs demonstrate excellent efficacy in suppressing tumour progression, recurrence, and metastasis in melanoma, breast cancer, and colon cancer models. This study pioneers a versatile nanoplatform that not only counteracts tumour immune evasion but also establishes durable anti‐tumour immunity, offering a transformative approach to tumour immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Key Laboratory of Stomatology, Department of Oral Biology & Clinic of Oral Rare…
- State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi International Joint Research Center for Oral Diseases, Center for Tissue Enginee…
- State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Key Laboratory of Stomatology, Digital Center, School of Stomatology, The Fourth…
- School of Chemistry and Chemical Engineering, Hubei Polytechnic University, Huangshi, Hubei, China.
- Department of Urology, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China.
- Guangzhou Institute of Cancer Research, School of Biomedical Engineering, the Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
Förderung
- National Postdoctoral Program for Innovative Talents of China
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Shaanxi Provincial Key Research and Development Plan Project
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Dou, G., Liu, J., Tian, R., Zhang, K., Suo, M., Zhou, D., Zhang, Y., Liu, X., Qiu, X., Kuang, J., Zou, Z., Wang, S., Zhao, L., Ding, F., Wang, D., Guan, C., Zhu, X., Wang, D., Liu, S., …, & Liu, S. (2026). Pyroptosis‐Amplified Decoy Nanovesicles Orchestrate Pyroptotic Antigen Explosion and Endogenous Immune Revitalization for Potentiating Tumour Immunotherapy. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.70356
Vancouver
Dou G, Liu J, Tian R, Zhang K, Suo M, Zhou D, et al. Pyroptosis‐Amplified Decoy Nanovesicles Orchestrate Pyroptotic Antigen Explosion and Endogenous Immune Revitalization for Potentiating Tumour Immunotherapy. Journal of Extracellular Vesicles. 2026. doi:10.1002/jev2.70356
BibTeX
@article{Dou2026,
author = {Dou, Geng and Liu, Jiani and Tian, Ran and Zhang, Keying and Suo, Meng and Zhou, Ding and Zhang, Yipeng and Liu, Xuemei and Qiu, Xinyu and Kuang, Jinxin and Zou, Zhaonan and Wang, Shuchang and Zhao, Lu and Ding, Feng and Wang, Di and Guan, Congcong and Zhu, Xiaoyu and Wang, Dongyao and Liu, Siying and Zhang, Tianfu and Zhao, Yimin and Liu, Shiyu},
title = {Pyroptosis‐Amplified Decoy Nanovesicles Orchestrate Pyroptotic Antigen Explosion and Endogenous Immune Revitalization for Potentiating Tumour Immunotherapy},
journal = {Journal of Extracellular Vesicles},
year = {2026},
doi = {10.1002/jev2.70356}
}
EUVIMED